Literature DB >> 8514628

Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physico-chemical and biological properties.

F Sasse1, H Steinmetz, G Höfle, H Reichenbach.   

Abstract

A new cytostatic compound, rhizopodin, was isolated from the culture broth of the myxobacterium, Myxococcus stipitatus. The compound inhibited growth of various animal cell cultures without killing the cells. The ID50, measured by an MTT assay, was 12 approximately 30 ng/ml, depending on the cell line. Especially cells growing fibroblast-like showed typical morphological changes. They became larger and within hour formed long branching and reticular runners. These morphological changes were irreversible. Rhizopodin suppresses bleb formation in K-562 cells, and therefore could act by interacting with protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514628     DOI: 10.7164/antibiotics.46.741

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  14 in total

Review 1.  Analysis of myxobacterial secondary metabolism goes molecular.

Authors:  Helge B Bode; Rolf Müller
Journal:  J Ind Microbiol Biotechnol       Date:  2006-02-21       Impact factor: 3.346

2.  Total synthesis and biological evaluation of monorhizopodin and 16-epi-monorhizopodin.

Authors:  K C Nicolaou; Xuefeng Jiang; Peter J Lindsay-Scott; Andrei Corbu; Sawako Yamashiro; Andrea Bacconi; Velia M Fowler
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-07       Impact factor: 15.336

Review 3.  Challenges and discoveries in the total synthesis of complex polyketide natural products.

Authors:  Ian Paterson; Nelson Yuen Sum Lam
Journal:  J Antibiot (Tokyo)       Date:  2017-10-25       Impact factor: 2.649

Review 4.  Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage.

Authors:  Patrick C Still; Tyler A Johnson; Christine M Theodore; Steven T Loveridge; Phillip Crews
Journal:  J Nat Prod       Date:  2014-02-26       Impact factor: 4.050

Review 5.  Isolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolides.

Authors:  Chad D Hopkins; Peter Wipf
Journal:  Nat Prod Rep       Date:  2009-03-11       Impact factor: 13.423

6.  Metabolic and evolutionary origin of actin-binding polyketides from diverse organisms.

Authors:  Reiko Ueoka; Agustinus R Uria; Silke Reiter; Tetsushi Mori; Petra Karbaum; Eike E Peters; Eric J N Helfrich; Brandon I Morinaka; Muriel Gugger; Haruko Takeyama; Shigeki Matsunaga; Jörn Piel
Journal:  Nat Chem Biol       Date:  2015-08-03       Impact factor: 15.040

7.  Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.

Authors:  Jennifer Herrmann; Yasser A Elnakady; Romina M Wiedmann; Angelika Ullrich; Manfred Rohde; Uli Kazmaier; Angelika M Vollmar; Rolf Müller
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

8.  Complete genome sequence of Myxococcus stipitatus strain DSM 14675, a fruiting myxobacterium.

Authors:  Stuart Huntley; Susanne Kneip; Anke Treuner-Lange; Lotte Søgaard-Andersen
Journal:  Genome Announc       Date:  2013-03-21

9.  Design, Synthesis, and Biological Evaluation of Novel 1,3-Oxazole Sulfonamides as Tubulin Polymerization Inhibitors.

Authors:  Edward Sisco; Korry L Barnes
Journal:  ACS Med Chem Lett       Date:  2021-05-25       Impact factor: 4.632

Review 10.  Macrocyclic drugs and synthetic methodologies toward macrocycles.

Authors:  Xufen Yu; Dianqing Sun
Journal:  Molecules       Date:  2013-05-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.